From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

E-Therapeutics: having bagged shares from sale of Searchbolt, CEO quits

By Nigel Somerville, the Deputy Sheriff of AIM | Wednesday 13 July 2016


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Tom Winnifrith described the deal under which AIM-listed E-Therapeutics (ETX) repurchased a company called Searchbolt (having spun it off some while back) as stinking like a pile of rotting kippers at the height of summer. In the event, two directors of E-Therapeutics ended up with (between them) almost 3.4 million shares in the company from the transaction. Now the CEO (who accounted for 3,350,228 of those shares – plus a cash sum to cover capital gains tax) has quit with immediate effect.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 17:36:40